Close Menu

marketing agreement

Starting next month, PGXL and Generation Health will provide pharmacogenetic testing and diagnostic services to patients through healthcare providers.

Under the deal, System Biosciences will convert many of DV Biologics' disease-specific cell types into induced pluripotent stem cell lines.

In clinical studies, the test demonstrated 97.1 percent positive agreement and 100 percent negative agreement with conventional methods of testing for MRSA, AdvanDx said.

1st Base will promote Protoemics International's proteomics services in Singapore, Malaysia, Indonesia, and Thailand.

The companies have integrated HTG's qBead technology for use on the Luminex xMAP multiplexing platform.

The term sheet agreement with GeneDiagnostics would cover marketing for the ColonSentry in Shanghai, Zhejiang, and Jiangsu.

Access will offer its web-based software with the Caliper LabChip GX system as an integrated molecular diagnostic platform.

Novartis Diagnostics will take the Bio-Seeq molecular diagnostic tests for infectious disease through clinical trials and on to commercialization.

Life Technologies will sell the kits for chromosomal abnormalities under the Applied Biosystems name. The agreement, however, does not include the US.

Enzo plans to seek approval for and market MultiGen's antenatal infectious disease tests in New York and in other US regions.

Pages

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.